← Browse by Condition
Medical Condition
astrocytoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1
NCT06161974 Phase 2
Recruiting
Study of Olutasidenib and Temozolomide in HGG
Enrollment
60 pts
Location
United States, Austr...
Sponsor
Rigel Pharmaceuticals
NCT06989086
Recruiting
FearLess in NeuroOncology
Enrollment
112 pts
Location
United States
Sponsor
Virginia Commonwealth Universi...
NCT03911388 Phase 1
Recruiting
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Enrollment
24 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center